This topic contains a solution. Click here to go to the answer

Author Question: The client states, I've never had such trouble breathing. What is a pulmonary embolus anyway? Which ... (Read 62 times)

imanialler

  • Hero Member
  • *****
  • Posts: 539
The client states, I've never had such trouble breathing. What is a pulmonary embolus anyway? Which response by the nurse is the most appropriate?
 
  1. A pulmonary embolus is a stationary blood clot that formed in your lung.
  2. An embolus is a piece of the injured blood vessel that is moving in your lung.
  3. A pulmonary embolus is a portion of a blood clot that has moved from its original location to your lung.
  4. A pulmonary embolus is an area of tissue in your lung that has lost its blood supply and has become necrotic.

Question 2

The nurse is addressing a group of clients who have experienced thromboembolic disorders. One of the clients states, My dad had a problem with clotting too much and so does my brother.
 
  Before responding to this comment, the nurse considers which information?
  1. A genetic deficiency of protein C can produce hypercoagulability.
  2. Familial eating habits can result in deficiency of vitamin C that would increase clotting.
  3. Genetic deficiency of C peptide is implicated in clotting disorders.
  4. If there is a genetic tendency to decreased C reactive protein (CRP) the clotting cascade is enhanced.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

paavo

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

Correct Answer: 3
Rationale 1: A stationary blood clot is a thrombus.
Rationale 2: An embolus is not a portion of blood vessel.
Rationale 3: A thrombus that detaches and moves is called an embolus. Because the thrombus has moved to the lung, it is called a pulmonary embolus.
Rationale 4: An embolus is not necrotic tissue, but presence of an embolus can cause tissue to become necrotic.
Global Rationale: A thrombus that detaches and moves is called an embolus. Because the thrombus has moved to the lung, it is called a pulmonary embolus. A stationary blood clot is a thrombus. An embolus is not a portion of blood vessel. An embolus is not necrotic tissue, but presence of an embolus can cause tissue to become necrotic.

Answer to Question 2

Correct Answer: 1
Rationale 1: Protein C is a natural anticoagulant. Too little would cause increased clotting.
Rationale 2: Vitamin C is not involved in clotting.
Rationale 3: C peptide is created in the process of insulin synthesis and is not associated with clotting.
Rationale 4: Deficiency of the inflammatory protein CRP would not cause increased clotting.
Global Rationale: Protein C is a natural anticoagulant. Too little would cause increased clotting. Vitamin C is not involved in clotting. C peptide is created in the process of insulin synthesis and is not associated with clotting. Deficiency of the inflammatory protein CRP would not cause increased clotting.




imanialler

  • Member
  • Posts: 539
Reply 2 on: Jul 23, 2018
Wow, this really help


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library